Pharma

Ajanta Pharma Ltd

AJANTPHARM · NSE · INE031B01049
——consolidatedstandalone
Vol: 92.3K traded · 63.8% delivered
Sentiment47 · Neutral
Extreme FearFearNeutralGreedExtreme Greed
Market Cap—
P/E—
P/B—
EPS—
Div Yield—
ROE25.4%
ROCE29.8%
ROE25.4%
1Y Return+25.92%
Avg. Volume0.1M
Delivery %63.75%

Price Chart

3,7183,3853,0522,7192,3865.1L10.1LOct 2025Nov 2025Jan 2026Feb 2026Mar 2026Apr 2026May 2026Jul 2026Oct 2026

About

Ajanta Pharma Ltd is a Pharma company listed on NSE.

Pharma

Technicals

Free account

Technicals

Create a free account to view momentum, moving averages, and delivery signals.

Register free

Quant

Premium

Quant metrics

Upgrade to view volatility, drawdown, factor, and risk metrics.

Upgrade

Key Ratios

Market Cap—
Current Price—
52W High / Low—
Stock P/E—
Price to Book—
EPS (TTM)—
Dividend Yield—
ROE25.4%
1Y Return+25.92%
Day Change—

Profit & Loss

ConsolidatedStandalone
Profit and loss statement
PeriodTTMFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Sales₹5,776 Cr₹5,453 Cr₹4,648 Cr
Expenses₹4,309 Cr₹3,953 Cr₹3,379 Cr
Operating Profit₹1,467 Cr₹1,500 Cr₹1,269 Cr
OPM %25.0%28.0%27.0%
Other Income₹217 Cr₹67 Cr₹85 Cr
Depreciation₹176 Cr₹173 Cr₹144 Cr
Interest₹14 Cr₹16 Cr₹21 Cr
Profit Before Tax₹1,493 Cr₹1,378 Cr₹1,189 Cr
Tax₹358 Cr₹322 Cr₹269 Cr
Net Profit₹1,135 Cr₹1,056 Cr₹920 Cr
EPS (₹)90.884.573.7
Dividend Payout %—33%38%
Financial history locked

Register free to see 10 more years.

Register free

Quarterly Results

Quarterly results
QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Sales₹1,626 Cr₹1,422 Cr₹1,375 Cr₹1,354 Cr
Expenses₹1,202 Cr₹1,088 Cr₹993 Cr₹1,026 Cr
Operating Profit₹424 Cr₹333 Cr₹382 Cr₹328 Cr
OPM %26.0%23.0%28.0%24.0%
Depreciation₹44 Cr₹45 Cr₹44 Cr₹43 Cr
Interest₹3 Cr₹2 Cr₹5 Cr₹3 Cr
Net Profit₹334 Cr₹267 Cr₹274 Cr₹260 Cr
EPS (₹)26.821.421.920.8
Quarterly history locked

Register free to see 9 more quarters.

Register free

Balance Sheet

Balance sheet
PeriodFY26FY25FY24FY23FY22FY21FY20FY19FY18FY17FY16FY15
Liabilities
Equity Capital₹25 Cr₹25 Cr₹25 Cr
Reserves₹4,502 Cr₹3,765 Cr₹3,542 Cr
Borrowings₹260 Cr₹47 Cr₹35 Cr
Other Liabilities₹1,250 Cr₹1,067 Cr₹928 Cr
Total Liabilities₹6,037 Cr₹4,904 Cr₹4,530 Cr
Assets
Fixed Assets₹1,867 Cr₹1,762 Cr₹1,479 Cr
Investments₹588 Cr₹464 Cr₹349 Cr
Receivables———
Inventory———
Cash & Equivalents———
Other Assets₹3,324 Cr₹2,502 Cr₹2,446 Cr
Total Assets₹6,037 Cr₹4,904 Cr₹4,530 Cr
Balance sheet history locked

Register free to see 10 more years.

Register free

Cash Flow

Cash flow statement
PeriodOperatingInvestingFinancingNet Cash Flow
FY26₹529 Cr₹-429 Cr₹-168 Cr₹-68 Cr
FY25₹1,157 Cr₹-377 Cr₹-733 Cr₹47 Cr
FY24₹785 Cr₹65 Cr₹-1,051 Cr₹-201 Cr
FY23
FY22
FY21
FY20
FY19
FY18
FY17
FY16
FY15
Cash flow history locked

Register free to see 10 more years.

Register free

Peer Comparison

Peer comparison
CompanyM.CapP/EROE1Y Return
3B BlackBio Dx Ltd₹1,210 Cr21.4+20.2%+17.9%
Aarey Drugs & Pharmaceuticals Ltd₹353 Cr75.3+2.75%+59.84%
Aarti Drugs Ltd₹3,429 Cr18.0+13.37%+11.57%
Aarti Pharmalabs Ltd₹7,495 Cr35.2+8.51%+14.26%
Abbott India Ltd——+34.46%-7.16%

Mutual Fund Holdings

Free account

Mutual fund holdings

Create a free account to see institutional ownership snapshots.

Register free

Bulk & Block Deals

Free account

Bulk & block deals

Create a free account to view recent institutional deal activity.

Register free

Analyst Estimates

Free account

Analyst estimates

Create a free account to view analyst estimate summaries.

Register free

Latest News

2026-08-31Participation In Investor ConferenceBSE Filing2026-07-30Ajanta Pharma Ltd (BOM:532331) (Q1 2027) Earnings Call Highlights: Strong Revenue Growth and ...GuruFocus.com

Documents & Filings

rupiya.io is for research and education only. Metrics shown are not investment advice. Validate with SEBI-regulated disclosures before acting.